Pulmonary hypertension (PH) in patients (pts) with CML treated with tyrosine kinase inhibitors (TKIs).

被引：1
|
作者：
Gaballa, S.
Al-Kali, A.
Kantarjian, H.
Jabbour, E.
Quintas-Cardama, A.
Ayoubi, M.
Borthakur, G.
O'Brien, S. M.
Cortes, J. E.
机构：
[1] Thomas Jefferson Univ, Philadelphia, PA 19107 USA
[2] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.6597
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6597
引用
收藏
页数：1
相关论文
共 50 条
  • [31] ASSOCIATION OF 3′BCR GENE DELETION WITH LACK OF MOLECULAR RESPONSE IN CML PATIENTS WITH PH-VARIANTS TREATED WITH TYROSINE KINASE INHIBITORS
    Angelova, S.
    Spassov, B.
    Tsvetkova, G.
    Balatzenko, G.
    Hrischev, V.
    Batschvarov, K.
    Hadjiev, E.
    Mihaylov, G.
    HAEMATOLOGICA, 2016, 101 : 732 - 732
  • [32] New drug approval: Asciminib for the treatment of adult patients with Ph plus CML previously treated with two or more tyrosine kinase inhibitors
    Rey, Gaelle
    Rousselot, Philippe
    BULLETIN DU CANCER, 2023, 110 (01) : 13 - 15
  • [33] MULTICENTER OPEN LABEL STUDY OF SUBCUTANEOUS (SC) OMACETAXINE (OMA) IN CHRONIC MYELOID LEUKEMIA (CML) PATIENTS (PTS) THAT ARE RESISTANT OR INTOLERANT TO TWO OR MORE TYROSINE KINASE INHIBITORS (TKIS)
    Cortes, J.
    Wetzler, M.
    Akard, L.
    Lipton, J. H.
    Benichou, A. C.
    Craig, A. R.
    Humphriss, E.
    Kantarjian, H.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 221 - 221
  • [34] Pooled safety analysis of omacetaxine mepesuccinate in patients with chronic myeloid leukemia (CML) resistant to tyrosine-kinase inhibitors (TKIs)
    Wetzler, Meir
    Kantarjian, Hagop
    Nicolini, Franck E.
    Lipton, Jeffrey Howard
    Akard, Luke Paul
    Baccarani, Michele
    Craig, Adam
    Brown, Peter D.
    Cortes, Jorge E.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [35] INCIDENCE OF SECONDARY NEOPLASMAS IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA (CML): CARCINOGENICITY OF TYROSINE KINASE INHIBITORS (TKIS) OR HIGHER CANCER PREDISPOSITION?
    Montero Cuadrado, M., I
    Dominguez, M. A.
    Blum, A.
    Portero, M. A.
    Gonzalez Campos, J.
    Falantes, J. F.
    Parody Porras, R.
    Martino Galiana, M. L.
    Perez Simon, J. A.
    HAEMATOLOGICA, 2015, 100 : 29 - 29
  • [36] Incidence and Outcomes of Chronic Myeloid Leukemia (CML) Patients (pts) with Other Chromosomal Abnormalities (OCA) Treated with Second Generation Tyrosine Kinase Inhibitors (TKI)
    Pemmaraju, Naveen
    Kantarjian, Hagop M.
    Jabbour, Elias J.
    Quintas-Cardama, Alfonso
    Borthakur, Gautam
    Burton, Elizabeth M.
    Dellasala, Sara E.
    Pierce, Sherry A.
    Kornblau, Steven M.
    Verstovsek, Srdan
    O'Brien, Susan
    Cortes, Jorge E.
    BLOOD, 2012, 120 (21)
  • [37] Disease Patterns for Patients (pts) with Chronic Myeloid Leukemia (CML) That Have BCR-ABL Transcript Levels > 10% At 3 Month of Therapy with Tyrosine Kinase Inhibitors (TKIs)
    Nazha, Aziz
    Kantarjian, Hagop M.
    Jain, Preetesh
    Jabbour, Elias J.
    Quintas-Cardama, Alfonso
    Luthra, Rajyalakshmi
    Abruzzo, Lynne V.
    Borthakur, Gautam
    Ravandi, Farhad
    Pierce, Sherry A.
    O'Brien, Susan
    Cortes, Jorge E.
    BLOOD, 2012, 120 (21)
  • [38] Treatment Outcomes in CML Patients Treated With Tyrosine Kinase Inhibitors at a Tertiary Teaching Hospital in South Africa
    Sissolak, Gerhard
    Badenhorst, Jacques
    Steenkamp, Janami
    Heaney, Mark
    Louw, Vernon
    Schnugh, Desmond
    Willem, Pascale
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2015, 15 (12): : 803 - 810
  • [39] UNFAVOURABLE OUTCOME OF CML PATIENTS CARRYING COMPLEX VARIANT CHROMOSOMAL TRANSLOCATIONS TREATED WITH TYROSINE KINASE INHIBITORS
    Stagno, F.
    Vigneri, P.
    Del Fabro, V.
    Stella, S.
    Cupri, A.
    Massimino, M.
    Consoli, C.
    Tambe, L.
    Consoli, M. L.
    Antolino, A.
    Spina, E.
    Di Raimondo, F.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 533 - 533
  • [40] Blast Phase in Chronic Myelogenous Leukemia (CML) Is Skewed towards Unusual Blast Types in Patients Treated with Tyrosine Kinase Inhibitors (TKIs): A Comparative Study of 67 Cases
    Rand, A.
    Crow, J.
    Moore, J. O.
    Lagoo, A. S.
    MODERN PATHOLOGY, 2012, 25 : 364A - 364A
12345